Cargando…
Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence
INTRODUCTION AND HYPOTHESIS: Polyacrylamide hydrogel (PAHG, Bulkamid®) is a promising urethral bulking agent. This article presents the 2-year follow-up results of a multicenter study of PAHG injections for treating stress and stress-predominant mixed urinary incontinence. METHODS: Submucosal inject...
Autores principales: | Toozs-Hobson, Philip, Al-Singary, Waleed, Fynes, Michelle, Tegerstedt, Gunilla, Lose, Gunnar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448051/ https://www.ncbi.nlm.nih.gov/pubmed/22531952 http://dx.doi.org/10.1007/s00192-012-1761-8 |
Ejemplares similares
-
An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence
por: Lose, Gunnar, et al.
Publicado: (2010) -
Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid(®)) in the management of stress and mixed urinary incontinence: three year follow up outcomes
por: Pai, Aakash, et al.
Publicado: (2015) -
Seven‐year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence
por: Brosche, Torsten, et al.
Publicado: (2021) -
Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence
por: Hoe, Venetia, et al.
Publicado: (2023) -
Long‐term outcomes of polyacrylamide hydrogel treatment in women with stress urinary incontinence
por: Hoe, Venetia, et al.
Publicado: (2022)